Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.57 |
| ▸ | ARG2 | P78540 | 4/20 | 0.52 |
| ▸ | ARG1 | P05089 | 3/20 | 0.52 |
| ▸ | NOS2 | P35228 | 5/20 | 0.50 |
| ▸ | NOS1 | P29475 | 4/20 | 0.50 |
| ▸ | NOS3 | P29474 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | OTC | P00480 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL623369 | 1.00 | GSR (0.57) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL432790 | 1.00 | GSR (0.57) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL6369985 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL28449339 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL25670261 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| Hydrochloric Acid SCHEMBL5971277 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| Hydrochloric Acid SCHEMBL8919761 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| Hydrochloric Acid SCHEMBL27243097 | 0.98 | GSR (0.55) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL3438660 | 0.94 | GSR (0.54) | GSRARG2ARG1NOS2NOS1 | |
| SCHEMBL31688818 | 0.94 | GSR (0.54) | GSRARG2ARG1NOS2NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6177 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745237-A1 | RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| EP-4720086-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | claimed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | claimed |
| WO-2025147774-A1 | COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING AND TREATMENT OF CANCER AND OTHER DISORDERS | ALPHA-9 ONCOLOGY INC. (CA) | 2025-07-17 | — | — | WO | claimed |
| EP-4583917-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2025-07-16 | — | — | EP | claimed |
| US-6596728-B1 | A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-07-22 | — | — | US | claimed |
| US-6432394-B2 | MIXTURE OF AMINO ACID, SURFACTANT, SILICONE AND WATER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC | 2002-08-13 | — | — | US | claimed |
| US-6358978-B1 | FOR THERAPY AND PROPHYLAXIS OF RHEUMATOID ARTHRITIS (IN THE CASE OF INFLAMMATION), OSTEOARTHRITIS, ASTHMA, CARDIAC INFARCT, ALZHEIMER'S DISEASE, OR ATHEROSCLEROSIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-03-19 | — | — | US | claimed |
| EP-1179538-A1 | PEPTIDES BLOCKING RESPONSE TO CHEMICAL SUBSTANCES OR THERMAL STIMULI OR NOCICEPTOR INFLAMMATION MEDIATORS AND COMPOSITIONS CONTAINING SAID PEPTIDES | Universidad Miguel Hernandez de Elche (ES) | 2002-02-13 | — | — | EP | claimed |
| US-20010008630-A1 | HAIR CONDITIONING COMPOSITIONS | UNILEVER HOME & PERSONAL CARE USA., DIVISION OF CONOPCO, INC. | 2001-07-19 | — | — | US | claimed |
| WO-2000062747-A1 | HAIR CONDITIONING COMPOSITIONS | UNILEVER PLC (GB) | 2000-10-26 | — | — | WO | claimed |
| EP-0920307-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1999-06-09 | — | — | EP | claimed |
| EP-0896583-A1 | NOVEL OSP-C DERIVED PEPTIDE FRAGMENTS | STATENS SERUMINSTITUT (DK) | 1999-02-17 | — | — | EP | claimed |
| WO-1998006386-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | ROCHE DIAGNOSTICS GMBH (DE) | 1998-02-19 | — | — | WO | claimed |
| WO-1997042221-A1 | NOVEL OSP-C DERIVED PEPTIDE FRAGMENTS | STATENS SERUMINSTITUT (DK) | 1997-11-13 | — | — | WO | claimed |